Clinical Trials Browser

Phase 1/2 × Adenoviridae Infections × CNS × Clear all

NCT06763965 2026-03-23

Evaluating the Safety and Efficacy of BioTTT001 in Patients With Recurrent/Progressive High-grade Glioma.

Phase 1/2 Enrolling by invitation

Adenoviridae Infections, Glioma